Our R&D Department

Yerlika develops pioneering solutions for the healthcare industry by prioritizing scientific innovation and technological advancement. Our R&D department focuses on sustainable and innovative approaches in biotechnology to improve human lives through groundbreaking projects.

Our R&D Vision

The primary goal of our R&D efforts is to create globally leading solutions in biotechnology that enhance the quality of life. By combining scientific innovation with sustainability principles, we aim to develop effective and accessible biotechnological products for challenging diseases.

Our Focus Areas

Our R&D team operates across a broad spectrum of biotechnology and pharmaceutical development:

  • Biosimilars: Development of biosimilar drugs to increase local production and reduce dependency on imports.
  • Monoclonal Antibodies: Targeted therapy solutions for cancer and autoimmune diseases.
  • Gene Therapies and Viral Vectors: Advanced gene therapy solutions and vector-based production systems.
  • Vaccine Development: Innovative vaccine projects for viral and bacterial diseases.
  • Formulation and Lyophilization: Custom formulation studies to enhance product stability.

Our Infrastructure and Capabilities

Yerlika’s R&D facilities meet international standards with modern laboratories and state-of-the-art equipment:

  • Advanced Biotechnology Laboratories: Optimized infrastructure for mammalian cell lines and recombinant protein production processes.
  • Single Use Bioreactors: Flexible production with single-use systems of 10L, 50L, and 500L capacities.
  • GMP-Compliant Operations: Adherence to GMP standards in drug development and manufacturing processes.

Innovation and Our Projects

  • Biosimilar drug projects developed in collaboration with international partners.
  • Targeted biotechnological treatments for rare diseases.
  • Adenovirus-based cancer vaccines and immunotherapy solutions.
  • TÜBİTAK-supported Covid-19 vaccine development and production projects.

Sustainability and Environmental Responsibility

Our R&D processes prioritize sustainability by minimizing environmental impacts. Enhancing energy efficiency and investing in eco-friendly technologies are among our top priorities for a better future.

Collaborations and Academic Support

We collaborate with universities, research centers, and international organizations to support scientific progress in our R&D activities. These partnerships enable knowledge sharing and the development of innovative solutions.

Our Future Goals

Yerlika aims to shape the future of the healthcare industry by developing next-generation biotechnological solutions. By integrating technologies such as artificial intelligence and data analytics into our processes, we strive to deliver more effective and faster solutions.

Our R&D department will continue to develop innovative projects by combining science and technology, ensuring lasting contributions to public health.